Type‐I Photodynamic Therapy Induced by Pt‐Coordination of Type‐II Photosensitizers into Supramolecular Complexes

Abstract

Platinum supramolecular complexes based on photosensitizers have garnered great interest in photodynamic therapy (PDT) due to Pt (II) centers as chemotherapeutic agents to eliminate tumor cells completely, which greatly improve the antitumor efficacy of PDT. However, in comparison to precursor photosensitizer ligand, the formed platinum supramolecular complexes typically exhibit inferior outcomes in terms of reactive oxygen species (ROS) generation. How to boost ROS generation in the formed platinum supramolecular complexes for enhanced PDT is an enticing yet highly challenging task. Here we report a Pt‐coordination‐based dimeric photosensitizer complex (Cz‐BTZ‐Py)2Pt(OTf)2. It is found that comparing with photosensitizer ligand Cz‐BTZ‐Py, the formed supramolecular complex exhibit redshifts of absorption wavelength as well as enhanced ROS generation efficiency. Moreover, type‐I ROS generation (O2•‐) is produced in the formed platinum supramolecular complexes mainly due to a reduced energy gap ΔEST resulting from exciton coupling between two photosensitizer ligands. And type‐I ROS (O2•‐) generation significantly amplifies the photodynamic therapy (PDT) outcomes. In vitro evaluation shows excellent photochemotherapy performance of (Cz‐BTZ‐Py)2Pt(OTf)2 nanoparticles. We anticipate this work would provide a novel approach to design type‐I photosensitizers for efficient PDT.